Prodrug approach: An overview of recent cases

V Abet, F Filace, J Recio, J Alvarez-Builla… - European journal of …, 2017 - Elsevier
In this review we highlight the most modern trends in the prodrug strategy. In drug research
and development, the prodrug concept has found a number of useful applications. Selected …

The dawn of a new era: tumor-targeting boron agents for neutron capture therapy

T Luo, W Huang, F Chu, T Zhu, B Feng… - Molecular …, 2023 - ACS Publications
Cancer is widely recognized as one of the most devastating diseases, necessitating the
development of intelligent diagnostic techniques, targeted treatments, and early prognosis …

Boron science

NS Hosmane - New technologies and applications, 2011 - api.taylorfrancis.com
What is boron? The question itself may not seem very significant to many people. Their
introduction to the word “boron” could come as the butt of a joke. Conan O'Brien made jokes …

Boron and nucleic acid chemistries: merging the best of both worlds

AR Martin, JJ Vasseur, M Smietana - Chemical Society Reviews, 2013 - pubs.rsc.org
At the intersection of nucleic acid and boron chemistries lies a thriving world of possibilities.
During the past decades, the merging of these research domains has led to fascinating …

The chaotropic effect as an orthogonal assembly motif for multi-responsive dodecaborate-cucurbituril supramolecular networks

W Wang, X Wang, J Cao, J Liu, B Qi, X Zhou… - Chemical …, 2018 - pubs.rsc.org
In aqueous solution, host–guest complexation is frequently driven by the hydrophobic effect,
which also constitutes a popular approach in the design of supramolecular assemblies …

Dendrimers: advancements and potential applications in cancer diagnosis and treatment—an overview

A Crintea, AC Motofelea, AS Șovrea, AM Constantin… - Pharmaceutics, 2023 - mdpi.com
Cancer is a leading cause of death worldwide, and the main treatment methods for this
condition are surgery, chemotherapy, and radiotherapy. These treatment methods are …

Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors

RF Barth, W Yang, G Wu, M Swindall… - Proceedings of the …, 2008 - National Acad Sciences
The purpose of the present study was to evaluate the effectiveness of a 3-carboranyl
thymidine analogue (3CTA), 3-[5-{2-(2, 3-dihydroxyprop-1-yl)-o-carboran-1-yl} pentan-1-yl] …

Synthesis and evaluation of thymidine kinase 1-targeting carboranyl pyrimidine nucleoside analogs for boron neutron capture therapy of cancer

HK Agarwal, A Khalil, K Ishita, W Yang… - European journal of …, 2015 - Elsevier
A library of sixteen 2nd generation amino-and amido-substituted carboranyl pyrimidine
nucleoside analogs, designed as substrates and inhibitors of thymidine kinase 1 (TK1) for …

Dendrimer and cancer: A patent review (2006–present)

X Cai, J Hu, J Xiao, Y Cheng - Expert opinion on therapeutic …, 2013 - Taylor & Francis
Introduction: Dendrimers were widely used in cancer diagnosis and therapy during the past
decade. The surface functionalities allow bioactive molecules such as imaging probes …

Nucleoside scaffolds and carborane clusters for boron neutron capture therapy: developments and future perspective

A Khalil, MSS Adam - Current Medicinal Chemistry, 2024 - benthamdirect.com
Nucleosides containing carboranes are one of the most important boron delivery agents for
boron neutron capture therapy, BNCT, which are good substrates of hTK1. The development …